Health In Tech furnished an investor presentation under Item 7.01, highlighting its AI-powered platform for self-funded health plans and reiterating 2026 revenue guidance of $45M-$50M.
Key takeaways
Furnished investor presentation under Regulation FD; not deemed filed for Exchange Act purposes.
2026 revenue guidance reiterated at $45M-$50M, with Q1 2026 revenue of $8.0M (+56% YoY).
Adjusted EBITDA of $1.2M in Q1 2026, up 163% YoY, indicating improving profitability.
Platform placed plan value of $82.0M as of Q1 2026, reflecting business scale.
Company has no plan or underwriting risk; fee-based model with recurring revenue.
Multiple growth pathways: more brokers, products, MGUs/carriers, and data monetization.